Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Mineola, NY
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Duncansville, PA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
York, PA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
York, PA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
El Paso, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Ft. Worth, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Lewisville, TX
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Lewisville, TX
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
St. George, UT
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
St. George, UT
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Roanoke, VA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Richland, WA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Richland, WA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Evans, GA
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Evans, GA
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Charlotte, NC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Wilmington, NC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Columbia, SC
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated:  4/10/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Status: Enrolling
Updated: 4/10/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Static vs. Articulating Antibiotic Spacer for PJI in TKA
A Randomized Clinical Trial of Static Versus Articulating Antibiotic Spacer for Treatment of Periprosthetic Joint Infection in Total Knee Arthroplasty
Status: Enrolling
Updated:  4/10/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Static vs. Articulating Antibiotic Spacer for PJI in TKA
A Randomized Clinical Trial of Static Versus Articulating Antibiotic Spacer for Treatment of Periprosthetic Joint Infection in Total Knee Arthroplasty
Status: Enrolling
Updated: 4/10/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated:  4/13/2017
Cooper University Hospital
mi
from
Camden, NJ
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated: 4/13/2017
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated:  4/13/2017
Universitetssjukhuset i Linkoping
mi
from
Linkoping,
IMproved PREdiction of Severe Sepsis in the Emergency Department
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein (HBP) Assay for Indicating the Presence, or Outcome, of Severe Sepsis (Including Septic Shock), Over 72 Hours, in Patients With Suspected Infection Following Emergency Department Admission.
Status: Enrolling
Updated: 4/13/2017
Universitetssjukhuset i Linkoping
mi
from
Linkoping,
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Mission Viejo, CA
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Centennial, CO
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Centennial, CO
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Denver, CO
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Denver, CO
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Largo, FL
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Largo, FL
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Miami, FL
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Winter Park, FL
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Baltimore, MD
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Minneapolis, MN
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Rochester, MN
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Chesterfield, MO
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Bellevue, NE
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Rochester, NY
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Charlotte, NC
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Tulsa, OK
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Rock Hill, SC
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Rock Hill, SC
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Dallas, TX
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
New Braunfels, TX
A 12-Week Study in Subjects With Refractory Chronic Cough
A 12-Week Study to Assess the Efficacy and Safety of AF 219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
New Braunfels, TX
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Mission Viejo, CA
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
San Jose, CA
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
San Jose, CA
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Colorado Springs, CO
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Largo, FL
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Largo, FL
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Charlotte, NC
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Tulsa, OK
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Dallas, TX
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
San Antonio, TX
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Bellevue, WA
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated:  4/17/2017
Afferent Investigative Site
mi
from
Greenfield, WI
An 8-Week Refractory Chronic Cough Study
A Randomized, Parallel, Double-Blind Study to Assess the Efficacy and Tolerability of AF-219 in Subjects With Refractory Chronic Cough
Status: Enrolling
Updated: 4/17/2017
Afferent Investigative Site
mi
from
Greenfield, WI
Click here to add this to my saved trials
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated:  4/17/2017
Tampa General Hospital
mi
from
Tampa, FL
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test
Status: Enrolling
Updated: 4/17/2017
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials